Glaukos (GKOS) Long-Term Investments (2017 - 2026)
Glaukos' (GKOS) quarterly Long-Term Investments came in at $19.8 million in Q1 2026, up 31.13% year-on-year from $15.1 million in Q1 2025, and up 1.54% on a QoQ basis from $19.5 million in Q4 2025.
Glaukos (GKOS) Long-Term Investments (2017 - 2026) Analysis & Trends
Glaukos (GKOS) has 10 years of Long-Term Investments data on file, last reported at $19.8 million in Q1 2026.
- On a quarterly basis, Long-Term Investments rose 31.13% year-over-year to $19.8 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 31.13% increase from a year earlier, with the FY2025 full-year figure at $19.5 million, up 32.65% from the prior year.
- Long-Term Investments for Q1 2026 stood at $19.8 million, up from $19.5 million in the prior quarter.
- Over the last five years, Long-Term Investments for GKOS reached as high as $19.8 million in Q1 2026 and fell as low as $7.2 million in Q1 2022.
- Historically, Long-Term Investments has averaged $12.8 million across 5 years, with a median of $12.6 million in 2024.
- Across the five-year window, Long-Term Investments climbed 11.76% in 2022 and surged 42.31% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $8.4 million in 2022, then surged by 38.1% to $11.6 million in 2023, then increased by 26.72% to $14.7 million in 2024, then jumped by 32.65% to $19.5 million in 2025, then advanced by 1.54% to $19.8 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $19.8 million in Q1 2026, $19.5 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | 19.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.80 Mn |
| Dec 31, 2025 | 19.50 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 17.20 Mn |
| Mar 31, 2025 | 15.10 Mn |
| Dec 31, 2024 | 14.70 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Jun 30, 2024 | 13.70 Mn |
| Mar 31, 2024 | 12.60 Mn |
| Dec 31, 2023 | 11.60 Mn |
| Sep 30, 2023 | 10.40 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Sep 30, 2022 | 7.60 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 7.20 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | 6.80 Mn |
| Jun 30, 2021 | 6.50 Mn |